Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men

Journal of Lipid Research

Volumn 44, Issue 5, 2003, Pages 986-993

  Couillard, Charles ^a   Vohl, Marie Claude ^a   Engert, James C ^c   Lemieux, Isabelle ^b   Houde, Alain ^a   Alméras, Natalie ^a,b   Prud'homme, Denis ^d   Nadeau, André ^a   Després, Jean Pierre ^a,b   Bergeron, Jean ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d McGill Univ Hlth Ctr Res Inst ^*

Author keywords

High density lipoprotein; Oral glucose tolerance test; Triglycerides; Very low density lipoprotein

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGED; APOC 3 GENE; ARTICLE; DIET RESTRICTION; DNA POLYMORPHISM; GENE; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; GENE FREQUENCY; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MULTIVARIATE ANALYSIS; OBESITY; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; TIME FACTORS; TRIGLYCERIDES; VARIATION (GENETICS); VISCERA;

EID: 10744233570     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300043-JLR200     Document Type: Article

References (49)

1. Mahley, R. W., T. L. Innerarity, S. C. Rall, Jr., and K. H. Weisgraber. 1984. Plasma lipoproteins: apolipoprotein structure and function. J. Lipid Res. 25: 1277-1294.
2. McConathy, W. J., J. C. Gesquiere, H. Bass, A. Tartar, J. C. Fruchart, and C. S. Wang. 1992. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J. Lipid Res. 33: 995-1003.
3. Ginsberg, H. N., N. A. Le, I. J. Goldberg, J. C. Gibson, A. Rubinstein, P. Wang-Iverson, R. Norum, and W. V. Brown. 1986. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins C-III and AI. Evidence that apolipoprotein C-III inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J. Clin. Invest. 78: 1287-1295.
4. Talmud, P. J., and S. E. Humphries. 1997. Apolipoprotein C-III gene variation and dyslipidaemia. Curr. Opin. Lipidol. 8: 154-158.
5. Rees, A., C. C. Shoulders, J. Stocks, D. J. Galton, and F. E. Baralle. 1983. DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet. 1: 444-446.
6. Salas, J., S. Jansen, J. Lopez-Miranda, J. M. Ordovas, P. Castro, C. Marin, M. A. Ostos, M. D. Bravo, J. Jimenez-Pereperez, A. Blanco, F. Lopez-Segura, and F. Perez-Jimenez. 1998. The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am. J. Clin. Nutr. 68: 396-401.
7. Tybjaerg-Hansen, A., B. G. Nordestgaard, L. U. Gerdes, O. Faergeman, and S. E. Humphries. 1993. Genetic markers in the apo AI-C-III-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis. 100: 157-169.
8. Benlian, P., C. Boileau, N. Loux, D. Pastier, J. Masliah, M. Coulon, M. Nigou, A. Ragab, J. Guimard, and J. B. Ruidavets. 1991. Extended haplotypes and linkage disequilibrium between 11 markers at the APOA1-C3-A4 gene cluster on chromosome 11. Am. J. Hum. Genet. 48: 903-910.
9. Xu, C. F., M. N. Nanjee, J. Savill, P. J. Talmud, F. Angelico, M. Del Ben, R. Antonini, B. Mazzarella, N. Miller and S. E. Humphries. 1990. Variation at the apolipoprotein (apo) AI-C-III-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am. J. Hum. Genet. 47: 429-439.
10. Ordovas, J. M., F. Civeira, J. Genest, Jr., S. Craig, A. H. Robbins, T. Meade, M. Pocovi, P. M. Frossard, U. Masharani, P. W. Wilson, D. N. Salem, R. H. Ward, and E. J. Schaefer. 1991. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis. 87: 75-86.
11. Humphries, S. E., R. E. Peacock, and P. J. Talmud. 1995. The genetic determinants of plasma cholesterol and response to diet. In Clinical Endocrinology and Metabolism: International Practice and Research. J. B. Betteridge, editor. Baillère Tindall, London. 797-824.
12. Tas, S., and N. A. Abdella. 1994. Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apolipoprotein-C-III gene polymorphism. Lancet. 343: 1194-1195.
13. Hoffer, M. J., E. J. Sijbrands, F. H. De Man, L. M. Havekes, A. H. Smelt, and R. R. Frants. 1998. Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. Eur. J. Clin. Invest. 28: 807-812.
14. Shoulders, C. C., T. T. Grantham, J. D. North, A. Gaspardone, F. Tomai, A. de Fazio, F. Versaci, P. A. Gioffre, and N. J. Cox. 1996. Hypertriglyceridemia and the apolipoprotein C-III gene locus: lack of association with the variant insulin response element in Italian school children. Hum. Genet. 98: 557-566.
15. Zeng, Q., M. Dammerman, Y. Takada, A. Matsunaga, J. L. Breslow, and J. Sasaki. 1995. An apolipoprotein C-III marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum. Genet. 95: 371-375.
16. Henderson, H. E., S. V. Landon, J. Michie, and G. M. Berger. 1987. Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidaemic phenotypes. Hum. Genet. 75: 62-65.
17. Aalto-Setälä, K., K. Kontula, T. Sane, M. Nieminen, and E. Nikkila. 1987. DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis. 66: 145-152.
18. Dallinga-Thie, G. M., X. D. Bu, M. van Linde-Sibenius Trip, J. I. Rotter, A. J. Lusis, and T. W. de Bruin. 1996. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J. Lipid Res. 37: 136-147.
19. Dammerman, M., L. A. Sandkuijl, J. L. Halaas, W. Chung, and J. L. Breslow. 1993. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc. Natl. Acad. Sci. USA. 90: 4562-4566.
20. Waterworth, D. M., J. Ribalta, V. Nicaud, J. Dallongeville, S. E. Humphries, and P. Talmud. 1999. ApoC-III gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation. 99: 1872-1877.
21. Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apo C-III gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
22. Surguchov, A. P., G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle. 1996. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 16: 941-947.
23. Björntorp, P. 1992. Abdominal fat distribution and disease: an overview of epidemiological data. Ann. Med. 24:15-18.
24. Kissebah, A. H., and G. R. Krakower. 1994. Regional adiposity and morbidity. Physiol. Rev. 74: 761-811.
25. Després, J. P., and B. Lamarche. 1993. Effects of diet and physical activity on adiposity and body fat distribution: Implications for the prevention of cardiovascular disease. Nutr. Res. Rev. 6: 137-159.
26. Lemieux, I., A. Pascot, C. Couillard, B. Lamarche, A. Tchernof, N. Alméras, J. Bergeron, D. Gaudet, G. Tremblay, D. Prud'homme, A. Nadeau, and J. P. Després. 2000. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 102: 179-184.
27. Tchernof, A., B. Lamarche, D. Prud'homme, A. Nadeau, S. Moorjani, F. Labrie, P. J. Lupien, and J. P. Després. 1996. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 19: 629-637.
28. van der Kooy, R. and J. C. Seidell. 1993. Techniques for the measurement of visceral fat: a practical guide. Int. J. Obes. 17: 187-196.
29. Behnke, A. R., and J. H. Wilmore. 1974. Evaluation and Regulation of Body Build and Composition. Prentice-Hall, Englewood Cliffs, NJ. 21-27.
30. Siri, W. 1956. The gross composition of the body. Adv. Biol. Med. Phys. 4: 239-280.
31. Després, J. P., D. Prud'homme, M. C. Pouliot, A. Tremblay, and C. Bouchard. 1991. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am. J. Clin. Nutr. 54: 471-477.
32. Ferland, M., J. P. Després, A. Tremblay, S. Pinault, A. Nadeau, S. Moorjani, P. J. Lupien, G. Thériault, and C. Bouchard. 1989. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br. J. Nutr. 61: 139-148.
33. Moorjani, S., A. Dupont, F. Labrie, P. J. Lupien, D. Brun, C. Gagné, M. Giguère, and A. Bélanger. 1987. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 36: 244-250.
34. Burstein, M., and J. Samaille. 1960. Sur un dosage rapide du cholesterol lié aux α- et β-lipoprotéines du sérum. Clin. Chim. Acta. 5: 609.
35. Gidez, L. I., G. J. Miller, M. Burstein, S. Slagle, and H. A. Eder. 1982. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 23: 1206-1223.
36. Laurell, C. B. 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 15: 45-52.
37. Avogaro, P., G. B. Bon, G. Cazzolato, and G. B. Quinci. 1979. Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet. 1: 901-903.
38. Lemieux, I., C. Couillard, A. Pascot, N. Bergeron, D. Prud'homme, J. Bergeron, A. Tremblay, C. Bouchard, P. Mauriège, and J. Després. 2000. The small, dense LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis. 153: 423-432.
39. Nilsson-Ehle, P., and R. Ekman. 1978. Specific assays for lipoprotein lipase and hepatic lipase activities of post-heparin plasma. In Protides of Biological Fluids. H. Peeters, editor. Pergamon Press, Oxford. 243-246.
40. St-Amand, J., S. Moorjani, P. J. Lupien, D. Prud'homme, and J. P. Després. 1996. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism. Metabolism. 45: 261-267.
41. Richterich, R., and H. Dauwalder. 1971. Zur bestimmung des plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphatase-dehydrogenase-methode. Schweiz. Med. Wochenscher. 101: 615-618.
42. Desbuquois, B., and G. D. Aurbach. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 33: 732-738.
43. Garenc, C., S. Aubert, J. Laroche, F. Rousseau, J. Bergeron, and P. Julien. 2001. Determination of the apoC3 C-482T and SstI allele frequencies in the population of Québec City. Can. J. Cardiol. 17(suppl. C): 192C.
44. Fodor, J. G., J. J. Frohlich, J. J. Genest, Jr., and P. R. McPherson. 2000. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. Can. Med. Assoc. J. 162: 1441-1447.
45. Xu, C. F., P. Talmud, and S. Humphries. 1994. Three new polymorphisms of the ApoAI-C-III-AIV gene cluster. Mol. Cell. Probes. 8: 331-332.
46. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173.
47. Esterbauer, H., E. Hell, F. Krempler, and W. Patsch. 1999. Allele-specific differences in apolipoprotein C-III mRNA expression in human liver. Clin. Chem. 45: 331-339.
48. Sacks, F. M., P. Alaupovic, L. A. Moye, T. G. Cole, B. Sussex, M. J. Stampfer, M. A. Pfeffer, and E. Braunwald. 2000. VLDL, apolipoproteins B, C-III, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial. Circulation. 102: 1886-1892.
49. Lemieux, S., and J. P. Després. 1994. Metabolic complications of visceral obesity: Contribution to the etiology of type II diabetes and implications for prevention and treatment. Diabete Metab. 20: 375-393.